News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teleflex Inc. (TFX) Awarded Group Purchasing Contract With Vizient For Non-Tunneled Central Venous Catheters



8/23/2017 8:01:07 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for vascular access, has announced a new three year Product Category contract with Vizient Inc. for non-tunneled central venous catheters. Vizient is the largest member-driven health care performance improvement company in the country.

“Agreements like these demonstrate our commitment to working with all parties in the healthcare system to offer technology at increased savings that helps clinicians improve outcomes while reducing healthcare costs.”

The new agreement for non-tunneled central venous catheters, which became effective August 1, 2017, provides Vizient’s members increased savings on contracts that offer Teleflex’s wide range of catheter kits, which are designed to protect patients against unnecessary catheter related complications.

“Teleflex is pleased to offer such an extensive line of products to Vizient members,” said Jake Newman, vice president and general manager, Vascular Access, Teleflex. “Agreements like these demonstrate our commitment to working with all parties in the healthcare system to offer technology at increased savings that helps clinicians improve outcomes while reducing healthcare costs.”

Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners.

© 2017 Teleflex Incorporated. All rights reserved. MC-003618

Contacts

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES